Skip to main content
# Title Research Member Research Year
141 Signet ring carcinoma of the stomach: impact on prognosis and outcome
Dr. Mayada Fawzy Sedik Farghaly 2018
142 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Dr. Mayada Fawzy Sedik Farghaly 2018
143 1. Concurrent Use of Capecitabine with Adjuvant
Radiotherapy in the Treatment of Patients with Breast
Cancer
Dr. Hanaan Ahmed Mohammed Ahmed 2018
144 Tri-modalities for bladder cancer in elderly: Trans-urethral resection, hypofractionated radiotherapy and gemcitabine Dr. Adel Gomaa Mohamed Gabr 2018
145 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Dr. Amen Hamdy Zaki Ali 2018
146 Signet ring carcinoma of the stomach: impact on prognosis and outcome
Dr. Ahmed Refaat Abdel Zaher Mubarak 2018
147 Signet ring carcinoma of the stomach: impact on prognosis and outcome
Dr. Hanaan Ahmed Mohammed Ahmed 2018
148 1. Concurrent Use of Capecitabine with Adjuvant
Radiotherapy in the Treatment of Patients with Breast
Cancer
Dr. Hanaan Ahmed Mohammed Ahmed 2018
149 Signet ring carcinoma of the stomach: impact on prognosis and outcome
Dr. Ahmed Refaat Abdel Zaher Mubarak 2018
150 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Dr. Amen Hamdy Zaki Ali 2018